Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$4.58 - $9.21 $524,309 - $1.05 Million
114,478 Added 78.09%
261,078 $1.8 Million
Q2 2022

Aug 15, 2022

SELL
$7.06 - $23.63 $3.43 Million - $11.5 Million
-485,272 Reduced 76.8%
146,600 $1.23 Million
Q1 2022

May 16, 2022

BUY
$21.6 - $27.79 $13.1 Million - $16.9 Million
607,341 Added 2475.81%
631,872 $14.4 Million
Q4 2021

Feb 14, 2022

SELL
$23.0 - $29.01 $4.04 Million - $5.1 Million
-175,766 Reduced 87.75%
24,531 $677,000
Q3 2021

Nov 15, 2021

SELL
$25.04 - $30.06 $27.7 Million - $33.2 Million
-1,104,635 Reduced 84.65%
200,297 $5.58 Million
Q2 2021

Aug 16, 2021

SELL
$27.43 - $32.7 $21.1 Million - $25.2 Million
-770,948 Reduced 37.14%
1,304,932 $38.3 Million
Q1 2021

May 17, 2021

BUY
$21.37 - $34.38 $24.9 Million - $40.1 Million
1,165,958 Added 128.14%
2,075,880 $65.9 Million
Q4 2020

Feb 16, 2021

BUY
$15.31 - $21.12 $13.9 Million - $19.2 Million
909,922 New
909,922 $18.9 Million
Q2 2020

Aug 14, 2020

SELL
$13.31 - $20.51 $198,638 - $306,091
-14,924 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$12.98 - $30.25 $13 Million - $30.2 Million
-998,257 Reduced 98.53%
14,924 $231,000
Q4 2019

Feb 14, 2020

BUY
$18.89 - $31.89 $19.1 Million - $32.3 Million
1,013,181 New
1,013,181 $30.3 Million
Q3 2019

Nov 14, 2019

SELL
$20.88 - $25.66 $17.8 Million - $21.9 Million
-853,761 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$20.52 - $26.45 $32.1 Million - $41.4 Million
-1,565,732 Reduced 64.71%
853,761 $21.5 Million
Q1 2019

May 15, 2019

BUY
$20.23 - $26.29 $26.3 Million - $34.1 Million
1,297,869 Added 115.71%
2,419,493 $59.8 Million
Q4 2018

Feb 14, 2019

BUY
$17.64 - $28.32 $7.69 Million - $12.4 Million
436,196 Added 63.64%
1,121,624 $20.7 Million
Q3 2018

Nov 14, 2018

BUY
$20.64 - $25.67 $14.1 Million - $17.6 Million
685,428 New
685,428 $17.6 Million

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.99B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.